chr17-55081103-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178509.6(STXBP4):āc.1409A>Gā(p.Asn470Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000016 in 1,559,624 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_178509.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STXBP4 | NM_178509.6 | c.1409A>G | p.Asn470Ser | missense_variant | 16/18 | ENST00000376352.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STXBP4 | ENST00000376352.6 | c.1409A>G | p.Asn470Ser | missense_variant | 16/18 | 2 | NM_178509.6 | P1 | |
STXBP4 | ENST00000434978.6 | c.1343A>G | p.Asn448Ser | missense_variant | 15/17 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152222Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000149 AC: 21AN: 1407284Hom.: 0 Cov.: 31 AF XY: 0.0000157 AC XY: 11AN XY: 699564
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152340Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.1409A>G (p.N470S) alteration is located in exon 16 (coding exon 14) of the STXBP4 gene. This alteration results from a A to G substitution at nucleotide position 1409, causing the asparagine (N) at amino acid position 470 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at